Japan Medical Dynamic Marketing, INC. Provides Consolidated Earnings Guidance for the First Half and Year Ending March 31, 2024
July 28, 2023 at 02:00 am EDT
Share
Japan Medical Dynamic Marketing, INC. provided consolidated earnings guidance for the first half and year ending March 31, 2024. For the first half, the Company expects net sales of JPY 10,800 million, operating profit of JPY 800 million, net income attributable to owners of parent of JPY 450 million and net income per share of JPY 17.11.
For the year, the Company expects net sales of JPY 23,300 million, operating profit of JPY 2,500 million, net income attributable to owners of parent of JPY 1,500 million and net income per share of JPY 57.03.
Japan Medical Dynamic Marketing, INC. is a Japan-based medical equipment provider. The Company is principally engaged in the import, development, manufacture and sale of medical equipment primarily in the field of orthopedic surgery. The Company has two segments. The Japan segment imports materials for osteosynthesis, artificial joints and spinal fixation devices from manufacturers, and sell them in Japan. The America segment is involved in the development and manufacture of materials for osteosynthesis, artificial joints, spinal fixation devices and other products, as well as the sale of medical equipment in North America. As of March 31, 2014, the Company had one subsidiary in the United States.
JAPAN MEDICAL DYNAMIC MARKETING, INC. 
